TSE:4544Healthcare
H.U. Group Holdings (TSE:4544) Valuation Check After New Alzheimer’s Biomarker Assay Launch
H.U. Group Holdings (TSE:4544) is back on investors’ radar after announcing the Lumipulse G pTau 217 CSF assay, a new Alzheimer’s related biomarker test for its automated LUMIPULSE G analyzers.
See our latest analysis for H.U. Group Holdings.
The new pTau 217 CSF assay lands at a time when H.U. Group Holdings’ short term share price momentum has been soft, with a 30 day share price return of 5.09% and a 90 day share price return of 14.63%, even though the 1 year total shareholder return of...